引用本文: | Yakoub-Agha I,Mary JY,Hulin C,Doyen C,Marit G,Benboubker L,Voillat L,Moreau P,Berthou C,Stoppa AM,Maloisel F,Rodon P,Dib M,Pegourie B,Casassus P,Slama B,Damaj G,Zerbib R,Harousseau JL,Mohty M,Facon T;Intergroupe Francophone du Myélome.Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome[J].European journal of haematology,2012,88(3):249-259. |